𝔖 Bobbio Scriptorium

✦ LIBER ✦

Apricitabine – a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugs

✍ Scribed by Cox, Susan; Southby, Justine

Book ID: 115314701
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 391 KB
Volume: 18
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543780802641337

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Non-Nucleoside Reve

ChemInform Abstract: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections: Strategies to Overcome Drug Resistance Development

✍ E. DE CLERCQ 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB

Single-dose tenofovir and emtricitabine

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

✍ Benjamin H Chi; Moses Sinkala; Felistas Mbewe; Ronald A Cantrell; Gina Kruse; Na 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 151 KB